Diseases & Research

Opportunistic Infections - Respiratory Viral

Fred Hutchinson Cancer Research Center scientists are focused on studying influenza and other respiratory viral infections in cancer patients in order to improve prevention and treatment efforts with the ultimate goal of saving lives.

See our Influenza Disease Page fore more information about our respiratory infection research ยป

Fast Facts

  • Respiratory viral infections can result in mild to life-threatening illnesses and can include the common cold, pneumonia, bronchitis and respiratory failure, among others. Because they are easily transmitted, such infections occur commonly in healthy populations. Immune-compromised patients are at high risk and are more likely to develop serious or even deadly infections.

  • There are limited treatment options for respiratory viral infections, and therefore early detection and isolation practices are critical to protect high-risk patients. Active prevention, such as influenza vaccination and hand hygiene, is critical to preventing the spread of these infections.

  • Symptoms of infection can include coughing, congestion, pain, mucus, sore throat, fever and more.

[back to top]

Detection & Diagnosis

Detecting and controlling parainfluenza virus among transplant patients – Infection control programs for hematopoietic cell transplantation patients that emphasize detecting symptoms before initiating infection control measures may not be adequate to prevent transmission of the asymptomatic parainfluenza virus. The finding comes from a study by Drs. Michael Boeckh, Lawrence Corey, Rhoda Morrow, Katherine Guthrie and collaborators. This difficulty in detecting parainfluenza virus means its incidence is likely underestimated with conventional testing methods, according to the study.

[back to top]

Treatment & Prognosis

Treating influenza in immune-compromised patients – When faced with novel strains of influenza that have limited treatment options – such as during the 2009 H1N1 influenza pandemic – health clinicians who are caring for patients with compromised immune systems should test for infections using polymerase chain reaction (PCR) testing, begin antiviral treatments early, and initiative aggressive infection control procedures. The recommendations were published in late 2009 by Drs. Michael Boeckh and Corey Casper following the seasonal H1N1 outbreak.

[back to top]

Seattle Cancer Care Alliance logo

Fred Hutch's clinical research breakthroughs are delivered to patients through our treatment arm, the SCCA.

Make an appointment
Healthy volunteers

Healthy volunteers are critical to prevention and early detection research.

Find a Study
Researcher in lab

Fred Hutch scientists are producing some of the most important breakthroughs in the prevention, early detection and treatment of cancer.

Donate to our Research
Fred Hutchinson Cancer Research Center is a world leader in research to prevent, detect and treat cancer and other life-threatening diseases.